Comprehensive treatment of malignant blood diseases: carrying out joint standardized and individualized combination chemotherapy and hematopoietic stem cell transplantation to treat all kinds of malignant blood diseases, so that the treatments of leukemia, lymphoma, myeloma and myelodysplastic syndromes have reached the domestic advanced level.
Combination of Chinese and Western medicines in the treatment of blood diseases: optimizing the application of combination of Chinese and Western medicines in the treatment of all kinds of blood diseases, especially in the treatment of hematopenia and anaphylactic purpura has achieved very good therapeutic effect.
Standardized treatment of pediatric acute leukemia: the department is the designated treatment specialty of "Shenhua Love Fund", "Jackie Chan Fund" and other funds, which effectively reduces the burden of treatment of pediatric leukemia, and has set up a special "Love Ward" for pediatric hematology. The "Love Ward" has standardized the standard treatment techniques for pediatric acute leukemia, making the efficacy of children's leukemia, especially pediatric acute lymphoblastic leukemia, reach the domestic advanced level.
Hematopoietic Stem Cell Transplantation: The department is the earliest specialty in China to carry out hematopoietic stem cell transplantation, and has become the largest and most advanced clinical stem cell transplantation treatment center in Northwest China. It has rich therapeutic experience in autologous hematopoietic stem cell transplantation, allogeneic hematopoietic stem cell transplantation (compatible or semi-compatible, hematological or non-hematological, umbilical cord blood, etc.), mixed hematopoietic stem cell transplantation and other treatments for malignant hematological diseases and severe aplastic anemia, with more than 50 cases of transplants annually, and the treatment of transplantation technology reaches the leading level in China. And in the stem cell treatment of various difficult to treat diseases, has carried out the mesenchymal stem cell treatment of pediatric cerebral palsy, motor neuron disease, multiple sclerosis, etc.; hematopoietic stem cell treatment of severe hepatitis, cirrhosis of the liver, diabetic foot, etc.; CD34 stem cell treatment of traumatic brain injury, neurological injuries, bone cartilage injuries, etc., and achieved significant therapeutic effects.
Difficult Blood Disease Diagnosis and Consultation Center: The Center for Blood Disease has complete diagnostic equipments for blood disease, and it is the first unit in Northwest China to carry out flow cytometry diagnosis of leukemia and genotyping, and it is now able to independently carry out HLA transplantation and typing, morphology of leukemia, cytogenetic, immunological and molecular biological diagnosis, FISH and PCR testing of oncogenes fused with hematologic diseases, testing of leukemia micro-residual disease, coagulation function testing, etc. The Center also has a number of other centers for blood disease diagnosis and consultation. The level of disease analysis and diagnosis is constantly improving under the careful consultation of experts in clinical hematology and experimental hematology, and the annual diagnosis of more than 200 difficult hematological diseases in and out of the province has provided a guarantee for correct diagnosis and treatment.
The only national stem cell treatment center in Northwest China -- Stem Cell Treatment Center of Lanzhou General Hospital of Lanzhou Military Region was formally established. It is understood that the center is approved by the Ministry of Health of the military region, one of the two blood disease centers in the army, Gansu Province, the largest blood disease treatment center, the National Society of Hematology Hematopoietic Stem Cell Transplantation Group members of the Department of Hematology of Lanzhou Military Region General Hospital was formed on the basis of.
In order to further promote the development of research and application of stem cell and tumor biotherapy in our province, and to explore the application of stem cell transplantation for the treatment of various tissue-damaging diseases and tumor biotherapy, "Regenerative Medicine - New Advances in Stem Cell Research and Gene Therapy", which was approved by the Continuing Education Committee of the Department of Health of Gansu Province and the Department of Health of Lanzhou Military Region, was hosted by Lanzhou Military Region General Hospital. -Stem cell research new progress and gene, stem cells and biological treatment of new progress and Lanzhou Military Region General Hospital stem cell treatment center inauguration ceremony" were held on the same day.